| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.052 | 0.3 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.3 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.3 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |